More than 7,000 cases of South Beach Beverage Company's SoBe Green Tea and SoBe Energy drinks have been recalled, PepsiCola division says. Products were distributed to convenience stores and other retail outlets in 11 states. Firm initiated Class II recall due to accidental presence of cough/cold active ingredient dextromethorphan, South Beach says in 1Dec. 13 release. Firm says contamination was caused by outside manufacturer, and error was brought to South Beach's attention by consumer complaints of nausea, vomiting, numbness, light-headedness, although no serious AEs have been reported...
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
Kumar takes over as acting director of the Center for Biologics Evaluation and Research’s Office of Therapeutic Products days after director Nicole Verdun was ousted.
Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.
While treatments for scleroderma are in development, none are approved for the condition that is associated with high morbidity and mortality. The European Medicines Agency says guidance on how to design development programs for the disorder is needed.
